Tech Company Financing Transactions

Corridor Pharmaceuticals Funding Round

On 6/30/2010, Corridor Pharmaceuticals raised $14.5 million in investment from Ben Franklin Technology Partners, Domain Associates and MedImmune Ventures.

Transaction Overview

Announced On
6/30/2010
Transaction Type
Venture Equity
Amount
$14,475,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1122 Kenilworth Dr. 401
Towson, MD 21204
USA
Email Address
Overview
Corridor Pharmaceuticals is a platform-based pulmonary and critical care company developing novel therapeutics forelevated arginase levels.
Profile
Corridor Pharmaceuticals LinkedIn Company Profile
Social Media
Corridor Pharmaceuticals Company Twitter Account
Company News
Corridor Pharmaceuticals News
Facebook
Corridor Pharmaceuticals on Facebook
YouTube
Corridor Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Mark Strobeck
  Mark Strobeck LinkedIn Profile  Mark Strobeck Twitter Account  Mark Strobeck News  Mark Strobeck on Facebook
Chief Scientific Officer
Peter Suzdak
  Peter Suzdak LinkedIn Profile  Peter Suzdak Twitter Account  Peter Suzdak News  Peter Suzdak on Facebook
VP - Finance
Anne Shiflett
  Anne Shiflett LinkedIn Profile  Anne Shiflett Twitter Account  Anne Shiflett News  Anne Shiflett on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2010: Rivertop Renewables venture capital transaction
Next: 6/30/2010: Kona Medical venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary